Sutro Biopharma (STRO) Asset Utilization Ratio (2018 - 2026)

Sutro Biopharma (STRO) posted Asset Utilization Ratio of 0.51 for Q4 2025, up 13.52% sequentially from 0.45 in Q3 2025, and up 243.61% YoY from 0.15 in Q4 2024.

Sutro Biopharma (STRO) Asset Utilization Ratio (2018 - 2026) Analysis & Trends

Sutro Biopharma has reported Asset Utilization Ratio for 8 years, with the latest figure at 0.51 in Q4 2025.

  • Quarterly Asset Utilization Ratio rose 243.61% year-over-year to 0.51 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.51 (up 243.61% YoY) and the FY2025 annual result came in at 0.37, up 152.6% from the prior year.
  • Asset Utilization Ratio climbed to 0.51 in Q4 2025 per STRO's latest filing, from 0.45 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.51 in Q4 2025 and troughed at 0.11 in Q3 2023.
  • A 5-year average of 0.24 and a median of 0.18 in 2022 frame the typical range for Asset Utilization Ratio.
  • The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio plunged 56.59% in 2024, then jumped 243.61% in 2025.
  • Over 5 years, Asset Utilization Ratio stood at 0.17 in 2021, then declined by 3.33% to 0.17 in 2022, then surged by 103.0% to 0.34 in 2023, then slumped by 56.59% to 0.15 in 2024, then surged by 243.61% to 0.51 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.51, 0.45, and 0.36 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 0.47
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.38
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.69
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 186.67
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.13
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 0.90
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.54
10 Sutro Biopharma 339.58 Mn 175.24 Mn - 0.49

Historic Data

Download Data
DateValue
Jun 30, 2026 0.49
Dec 31, 2025 0.51
Sep 30, 2025 0.45
Jun 30, 2025 0.36
Mar 31, 2025 0.19
Dec 31, 2024 0.15
Sep 30, 2024 0.34
Jun 30, 2024 0.38
Mar 31, 2024 0.35
Dec 31, 2023 0.34
Sep 30, 2023 0.11
Jun 30, 2023 0.14
Mar 31, 2023 0.19
Dec 31, 2022 0.17
Sep 30, 2022 0.18
Jun 30, 2022 0.15
Mar 31, 2022 0.16
Dec 31, 2021 0.17
Sep 30, 2021 0.16
Jun 30, 2021 0.19